RecallRadar

FDA Device recall Z-1929-2015

Triglycerides GPO. In vitro test for the quantitative determination of triglycerides in human serum and plasma on the COBAS Integra 800 and…

On 2015-07-08 the FDA classified a Class II recall of Triglycerides GPO. In vitro test for the quantitative determination of triglycerides in human serum and plasma on the COBAS Integra 800 and… by Roche Diagnostics Operations, citing possible drug interference when using the Trinder reaction method on multiple Cobas Analyzers. Results of Trinder tests may be falsely decreased when the tests are run with urine….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1929-2015
ClassificationClass II
Statusterminated
Initiated2015-05-07
Published2015-07-08
Last updated2026-09-13 11:53 UTC
CompanyRoche Diagnostics Operations
DistributionUS

Product

Triglycerides GPO. In vitro test for the quantitative determination of triglycerides in human serum and plasma on the COBAS Integra 800 and 400 plus systems, cobas c111, Roche/Hitachi MODULAR systems, and cobas c systems.

Reason

Possible drug interference when using the Trinder reaction method on multiple Cobas Analyzers. Results of Trinder tests may be falsely decreased when the tests are run with urine samples (Creatinine plus and Uric Acid applications only) or blood samples collected before sufficient time has lapsed after the administration of the drugs Acetaminophen and N-acetylcysteine.

Identifiers

code_infoCatalog Numbers: 04657594190; 20767107322; 05171407190; 20767107322; 11730711216; 11876023216; 11876040216; 11488872216.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1929-2015%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.